Display options
Cite
Saeed U, Waheed Y, Ashraf M, et al. Estimation of Hepatitis B Virus, Hepatitis C Virus, and Different Clinical Parameters in the Thalassemic Population of Capital Twin Cities of Pakistan. Virology (Auckl). 2015;6:11-6doi: 10.4137/VRT.S31744.
Saeed, U., Waheed, Y., Ashraf, M., Waheed, U., Anjum, S., & Afzal, M. S. (2015). Estimation of Hepatitis B Virus, Hepatitis C Virus, and Different Clinical Parameters in the Thalassemic Population of Capital Twin Cities of Pakistan. Virology : research and treatment, 611-6. https://doi.org/10.4137/VRT.S31744
Saeed, Umar, et al. "Estimation of Hepatitis B Virus, Hepatitis C Virus, and Different Clinical Parameters in the Thalassemic Population of Capital Twin Cities of Pakistan." Virology : research and treatment vol. 6 (2015): 11-6. doi: https://doi.org/10.4137/VRT.S31744
Saeed U, Waheed Y, Ashraf M, Waheed U, Anjum S, Afzal MS. Estimation of Hepatitis B Virus, Hepatitis C Virus, and Different Clinical Parameters in the Thalassemic Population of Capital Twin Cities of Pakistan. Virology (Auckl). 2015 Nov 05;6:11-6. doi: 10.4137/VRT.S31744. eCollection 2015. PMID: 26568681; PMCID: PMC4636113.
Copy Download .nbib Format: NLM
Share it on

Virology (Auckl). 2015 Nov 05;6:11-6. doi: 10.4137/VRT.S31744. eCollection 2015.

Estimation of Hepatitis B Virus, Hepatitis C Virus, and Different Clinical Parameters in the Thalassemic Population of Capital Twin Cities of Pakistan.

Virology : research and treatment

Umar Saeed, Yasir Waheed, Muhammad Ashraf, Usman Waheed, Sadia Anjum, Muhammad Sohail Afzal

Affiliations

  1. Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology (NUST), Islamabad, Pakistan.
  2. Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology (NUST), Islamabad, Pakistan. ; Foundation University Medical College, Foundation University Islamabad, DHA Phase I, Islamabad, Pakistan.
  3. Safe Blood Transfusion Programme, Ministry of National Health Services, Government of Pakistan.
  4. Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology (NUST), Islamabad, Pakistan. ; Department of Chemistry, School of Sciences, University of Management and Technology (UMT), Lahore, Pakistan.

PMID: 26568681 PMCID: PMC4636113 DOI: 10.4137/VRT.S31744

Abstract

Hepatitis B and C are serious public health problems worldwide. Thalassemia patients are dependent on blood transfusions throughout their life and are at high risk of viral infections. The aim of this study was to estimate the prevalence of hepatitis B/C infections and different clinical parameters in multitransfused thalassemia population. In this study, 262 multitransfused β-thalassemia patients were enrolled from the capital twin cities of Pakistan. The presence of hepatitis B virus (HBV)/hepatitis C virus (HCV), alanine aminotransferase (ALT) level, serum creatinine, serum ferritin, hepatomegaly, splenomegaly, and splenectomy were analyzed. The overall prevalence of HBV and HCV was 3.08% and 55.73%, respectively, with 100% of patients older than 20 years had HCV infection. The ALT levels among HBV- and HCV-positive thalassemia patients were 92.62 ± 41.57 U/L and 98 ± 63.65 U/L, respectively; creatinine values observed were 0.4 ± 0.35 mg/dL (for HBV) and 0.39 ± 0.24 mg/dL (for HCV), while serum ferritin levels were 6865.87 ± 1649.13 ng/dL (for HBV) and 5445.95 ± 3059.28 ng/dL (for HCV). A total of 74.8% and 82.20% of HBV- and HCV-positive patients had hepatomegaly with an average increase in liver size of 4.17 and 4.33 cm, respectively. Splenomegaly was observed in 64.9% and 67.12% of HBV- and HCV-positive patients with an average increase in spleen size of 4 and 4.46 cm, respectively. Splenectomy was observed among 14.50% and 15.75% of HBV- and HCV-infected thalassemia patients. There is a strong need to properly screen blood before transfusions to reduce the future load of viral hepatitis from Pakistan.

Keywords: hepatitis B virus; hepatitis C virus; hepatomegaly; splenectomy; splenomegaly; thalassemic patients; transfusions

References

  1. J Infect Dev Ctries. 2008 Oct 01;2(5):373-8 - PubMed
  2. Epidemiol Infect. 1997 Dec;119(3):349-56 - PubMed
  3. World J Virol. 2013 Aug 12;2(3):136-8 - PubMed
  4. Libyan J Med. 2008 Jun 01;3(2):66-70 - PubMed
  5. N Engl J Med. 2002 Oct 10;347(15):1162-8 - PubMed
  6. Hepat Mon. 2012 Sep;12(9):e6142 - PubMed
  7. Asian Pac J Trop Med. 2015 Feb;8(2):85-9 - PubMed
  8. Hepatology. 2006 Aug;44(2):341-51 - PubMed
  9. World J Virol. 2015 Feb 12;4(1):33-5 - PubMed
  10. Ann Saudi Med. 1996 Nov;16(6):702-3 - PubMed
  11. World J Gastroenterol. 2009 Dec 7;15(45):5647-53 - PubMed
  12. J Pak Med Assoc. 2002 Sep;52(9):398-402 - PubMed
  13. Asian J Transfus Sci. 2010 Jul;4(2):94-8 - PubMed
  14. Indian J Pathol Microbiol. 1999 Oct;42(4):475-82 - PubMed
  15. Virol J. 2011 Mar 06;8:102 - PubMed
  16. J Hepatol. 2003;39 Suppl 1:S3-25 - PubMed
  17. J Pak Med Assoc. 1995 Oct;45(10):269-71 - PubMed
  18. J Viral Hepat. 2004 Mar;11(2):97-107 - PubMed
  19. Indian Pediatr. 2004 Oct;41(10):1072-3 - PubMed

Publication Types